Cited by 7Diabetes Management and ResearchDiabetes Management and EducationDiabetes Treatment and Management

Automated insulin delivery in elderly with type 1 diabetes: a prespecified analysis of the extension phase

Open access
Kudva, Yogish C., Henderson, Robert J., Kanapka, Lauren G., Weinstock, Ruth S., Rickels, Michael R., Pratley, Richard E., Chaytor, Naomi, Janess, Kamille +12 more·2025·Diabetes Technology & Therapeutics

Abstract

The Automated Insulin Delivery in Elderly with Type 1 Diabetes (AIDE T1D) trial randomized 82 adults ≥65 years with type 1 diabetes (T1D) to hybrid closed loop (HCL), predictive low glucose suspend (PLGS), and sensor-augmented pump (SAP) therapy in a randomized crossover trial. Seventy-five of the 78 completers joined an extension phase in which they were offered the pump mode of their choice for an additional 3 months. Mean age was 71 ± 4 years (range 65-86 years) and mean duration of T1D was 42 ± 17 years (range 1-68 years). Use of HCL was selected by 91%, PLGS by 8%, and continuous glucose monitoring with injections by 1%. For participants selecting HCL, time-in-range 70-180 mg/dL was similar in the randomized controlled trial and extension phase (mean 75% ± 10%). One severe hypoglycemic event was reported. HCL was preferred over PLGS or SAP and remained effective in older adults with T1D. Clinical Trial Registration: NCT04016662.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1089/dia.2024.0560

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In the extension phase of the AIDE T1D study, 91% of the participants chose the AID system.

    “In the extension phase of the study, 91% of the participants chose the AID system (55).”

    From 13. Older Adults: Standards of Care in Diabetes—2026 (2026) · cites this paper as [55]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. [2]2. Kudva YC, , Henderson RJ, , Kanapka LG, et al. Automated insulin delivery in older adults with Type 1 Diabetes. NEJM Evid, 2025; 4(1):EVIDoa2400200; doi: 10.1056/EVIDoa2400200 [DOI] [PMC free article] [PubMed] [Google Scholar] · DOI · Paper page
  2. [4]4. McAuley SA, , Trawley S, , Vogrin S, et al. Closed-Loop insulin delivery versus sensor-augmented pump therapy in older adults with Type 1 Diabetes (ORACL): A randomized, crossover trial. Diabetes Care, 2022; 45(2):381–390; doi: 10.2337/dc21-1667 [DOI] [PubMed] [Google Scholar] · DOI · Paper page

Cited by

Sorted by citations

Authors
Kudva, Y. C., Henderson, R. J., Kanapka, L. G., Weinstock, R. S., Rickels, M. R., Pratley, R. E., Chaytor, N., Janess, K., Desjardins, D., Pattan, V., Peleckis, A. J., Casu, A., Rizvi, S. R., Bzdick, S., Whitaker, K. J., Kamimoto, J. L. J., Miller, K., Kollman, C., Beck, R. W., & for the AIDE study group
Affiliations
  • Mayo Clinic (US)
  • Jaeb Center for Health Research (US)
  • SUNY Upstate Medical University (US)
  • University of Pennsylvania (US)
  • AdventHealth Orlando (US)
  • Washington State University Spokane (US)
  • Elkhart Clinic (US)
  • T1D Exchange (US)
Venue
Diabetes Technology & Therapeutics
Published
2025-03-11
Volume
27
Issue
7
Pages
572-575
ISSN
  • 1520-9156 (ISSN-L)
  • 1557-8593
OpenAlex
W4408328596
Cited by
7
References
3
Citations by year
2026: 3 · 2025: 4
FWCI
4.77
Type
journal article
Language
en
Open access
Locations
  • Diabetes Technology & Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion)
Funders
  • National Institutes of Health (UL1TR001878)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK122603)
  • National Center for Advancing Translational Sciences
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
type 1 diabetes, older adults, artificial pancreas, hybrid closed-loop system, predictive low glucose suspend, sensor-augmented pump, continuous glucose monitoring, time in range, hypoglycemia, extension phase
MeSH terms
Aged, Aged, 80 and over, Blood Glucose, Diabetes Mellitus, Type 1, Female, Humans, Hypoglycemia, Hypoglycemic Agents, Insulin, Insulin Infusion Systems, Male, Blood Glucose Self-Monitoring, Cross-Over Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review